Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

CEC levels may be a useful marker for predicting prostate cancer progression.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Innovative methods are reducing animal testing and improving biomedical research.

Skin-derived stem cells grow faster and are easier to obtain than hair follicle stem cells, but both can become various cell types.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Prostaglandin helps regenerate hair follicles after radiation damage.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Low zinc levels may be linked to the return of gynecologic cancers.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.